-
1
-
-
0026671408
-
Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin
-
Honig PK, Dale C, Woosley RL, et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
-
(1992)
Clin Pharmacol Ther
, vol.52
, pp. 231-238
-
-
Honig, P.K.1
Dale, C.2
Woosley, R.L.3
-
2
-
-
0027468346
-
Terfenadine-ketoconazole interaction, pharmacokinetic and electrocardiographic consequences
-
Honig PK, Wortham DC, Zamani K, et al. Terfenadine-ketoconazole interaction, pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-8.
-
(1993)
JAMA
, vol.269
, pp. 1513-1518
-
-
Honig, P.K.1
Wortham, D.C.2
Zamani, K.3
-
3
-
-
0000935587
-
Efficacy and safety of Fexofenadine HCL in fall seasonal allergic rhinitis
-
Tinkelman D, Falliers C, Bronsky E, et al. Efficacy and safety of Fexofenadine HCL in fall seasonal allergic rhinitis [Abstract]. J Allergy Clin Immunol 1996;97:435.
-
(1996)
J Allergy Clin Immunol
, vol.97
, pp. 435
-
-
Tinkelman, D.1
Falliers, C.2
Bronsky, E.3
-
4
-
-
0013509843
-
Fexofenadine: A new non-sedating antihistamine is effective in the treatment of seasonal allergic rhinitis
-
Bernstein D, Schoenwetter W, Nathan R, et al. Fexofenadine: a new non-sedating antihistamine is effective in the treatment of seasonal allergic rhinitis [Abstract]. J Allergy Clin Immunol 1996;97:435.
-
(1996)
J Allergy Clin Immunol
, vol.97
, pp. 435
-
-
Bernstein, D.1
Schoenwetter, W.2
Nathan, R.3
-
5
-
-
0004874133
-
Controlled pollen exposure - A new method of assessing drug efficacy
-
Day JH, Clark RH, Gow D, Gibson M. Controlled pollen exposure - a new method of assessing drug efficacy [Abstract], N Engl Reg Allergy Proc 1988;9:298.
-
(1988)
N Engl Reg Allergy Proc
, vol.9
, pp. 298
-
-
Day, J.H.1
Clark, R.H.2
Gow, D.3
Gibson, M.4
-
6
-
-
1842323350
-
Controlled pollen challenge is valuable in the assessment of anti-allergic medications
-
Day JH, Clark RH, Briscoe M, Dhillon M. Controlled pollen challenge is valuable in the assessment of anti-allergic medications [Abstract]. Clin Invest Med 1991;14(4):A5.
-
(1991)
Clin Invest Med
, vol.14
, Issue.4
-
-
Day, J.H.1
Clark, R.H.2
Briscoe, M.3
Dhillon, M.4
-
7
-
-
0029788985
-
Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure
-
Donovan JP, Buckeridge DL, Briscoe MP, et al. Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure. Ann Allergy Asthma Immunol 1996;77:74-80.
-
(1996)
Ann Allergy Asthma Immunol
, vol.77
, pp. 74-80
-
-
Donovan, J.P.1
Buckeridge, D.L.2
Briscoe, M.P.3
-
8
-
-
0029882966
-
A randomized, double-blind, placebo-controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis
-
Day JH, Briscoe MP, Buckeridge D. et al. A randomized, double-blind, placebo-controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996; 97:1050-7.
-
(1996)
J Allergy Clin Immunol
, vol.97
, pp. 1050-1057
-
-
Day, J.H.1
Briscoe, M.P.2
Buckeridge, D.3
-
9
-
-
0024244921
-
Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action
-
Oei HD. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Ann Allergy 1988;61:436-9.
-
(1988)
Ann Allergy
, vol.61
, pp. 436-439
-
-
Oei, H.D.1
-
10
-
-
0021229627
-
1 antagonists antihistamines, terfenadine and astemizole, for hay fever
-
1 antagonists antihistamines, terfenadine and astemizole, for hay fever. Thorax 1984;39:668-72.
-
(1984)
Thorax
, vol.39
, pp. 668-672
-
-
Howarth, P.H.1
Holgate, S.T.2
|